Lei Liu

13PUBLICATIONS
43CO-AUTHORS
Molecular targetsEthical use of new technologyBioinformatic methods developmentChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 11, 2025
Anti-LAG-3 Antibody LBL-007 plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 Trial.

Dongchen Sun, Gang Chen, Yu Chen

|Sep 18, 2025
[Interpretation and Examples: Key Updates in SPIRIT 2025 Statement].

Zelei Dai, Renjie Zhao, Kefan Li

|Sep 18, 2025
[Interpretation and Examples: Key Updates in CONSORT 2025].

Zelei Dai, Renjie Zhao, Kefan Li

|Apr 28, 2025
Efficacy, safety and single-cell analysis of neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma: a phase II trial.

Zhongzheng Xiang, Xiaoyuan Wei, Zhuoyuan Zhang

|Apr 14, 2024
Is postmastectomy radiotherapy necessary for breast cancer patients with clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy?

Chen-Feng Tan, Jun Wang, Xiao-Rong Zhong

|Jul 18, 2023
Survival and Trends in Annualized Hazard Function by Age at Diagnosis Among Chinese Breast Cancer Patients Aged ≤40 Years: Case Analysis Study.

Jun Wang, Ting Luo, Zhong-Zheng Xiang

Pageof 3

Frequent Collaborators

5 joint publications

Zhongzheng Xiang

3 joint publications

Jun Wang

3 joint publications

Tian Yang

3 joint publications

Zelei Dai